Synopsis
Synopsis
0
JDMF
0
KDMF
0
NDC API
0
VMF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 2,14-di-(demethoxy)-2-glucosidoxy-14- Methylthiocolchicine
2. Coltramyl
3. Miorel
4. Myoplge
5. Thiocolchicoside
1. Coltramyl
2. Thiocolchicine Glycoside
3. Coltrax
4. Miorel
5. N-[1,2-dimethoxy-10-methylsulfanyl-9-oxo-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-6,7-dihydro-5h-benzo[a]heptalen-7-yl]acetamide
6. Nsc624673
7. 2-demethoxy-2-glucosidoxythiocolchicine
8. Nsc-147755
9. Thiocolchicoside-d3
10. Prestwick_875
11. Prestwick0_000539
12. Prestwick1_000539
13. Prestwick2_000539
14. Prestwick3_000539
15. Bspbio_000557
16. Mls002153865
17. 602-41-5 (unlabeled)
18. Schembl719194
19. Spbio_002478
20. Bpbio1_000613
21. Chembl1705373
22. Chebi:91529
23. Hms1569l19
24. Hms2096l19
25. Hms2234k08
26. Bdbm50248250
27. N-[1,2-dimethoxy-10-methylsulfanyl-9-oxo-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-6,7-dihydro-5h-benzo[a]heptalen-7-yl]acetamide
28. Smr001233221
29. Sr-01000841233
30. Q1165293
31. Sr-01000841233-2
32. Brd-a11605036-001-03-2
33. N-(3-(hexopyranosyloxy)-1,2-dimethoxy-10-(methylthio)-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl)acetamide
| Molecular Weight | 563.6 g/mol |
|---|---|
| Molecular Formula | C27H33NO10S |
| XLogP3 | -0.4 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 11 |
| Rotatable Bond Count | 7 |
| Exact Mass | 563.18251742 g/mol |
| Monoisotopic Mass | 563.18251742 g/mol |
| Topological Polar Surface Area | 189 Ų |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 1010 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 5 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] EU WC
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
| Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
|---|
Upgrade, download data, analyse, strategize, subscribe with us 
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
57
PharmaCompass offers a list of Thiocolchicoside API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Thiocolchicoside manufacturer or Thiocolchicoside supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Thiocolchicoside manufacturer or Thiocolchicoside supplier.
PharmaCompass also assists you with knowing the Thiocolchicoside API Price utilized in the formulation of products. Thiocolchicoside API Price is not always fixed or binding as the Thiocolchicoside Price is obtained through a variety of data sources. The Thiocolchicoside Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tiocolchicoside [DCIT] manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tiocolchicoside [DCIT], including repackagers and relabelers. The FDA regulates Tiocolchicoside [DCIT] manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tiocolchicoside [DCIT] API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tiocolchicoside [DCIT] manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tiocolchicoside [DCIT] supplier is an individual or a company that provides Tiocolchicoside [DCIT] active pharmaceutical ingredient (API) or Tiocolchicoside [DCIT] finished formulations upon request. The Tiocolchicoside [DCIT] suppliers may include Tiocolchicoside [DCIT] API manufacturers, exporters, distributors and traders.
click here to find a list of Tiocolchicoside [DCIT] suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tiocolchicoside [DCIT] DMF (Drug Master File) is a document detailing the whole manufacturing process of Tiocolchicoside [DCIT] active pharmaceutical ingredient (API) in detail. Different forms of Tiocolchicoside [DCIT] DMFs exist exist since differing nations have different regulations, such as Tiocolchicoside [DCIT] USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tiocolchicoside [DCIT] DMF submitted to regulatory agencies in the US is known as a USDMF. Tiocolchicoside [DCIT] USDMF includes data on Tiocolchicoside [DCIT]'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tiocolchicoside [DCIT] USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tiocolchicoside [DCIT] suppliers with USDMF on PharmaCompass.
A Tiocolchicoside [DCIT] CEP of the European Pharmacopoeia monograph is often referred to as a Tiocolchicoside [DCIT] Certificate of Suitability (COS). The purpose of a Tiocolchicoside [DCIT] CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Tiocolchicoside [DCIT] EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Tiocolchicoside [DCIT] to their clients by showing that a Tiocolchicoside [DCIT] CEP has been issued for it. The manufacturer submits a Tiocolchicoside [DCIT] CEP (COS) as part of the market authorization procedure, and it takes on the role of a Tiocolchicoside [DCIT] CEP holder for the record. Additionally, the data presented in the Tiocolchicoside [DCIT] CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Tiocolchicoside [DCIT] DMF.
A Tiocolchicoside [DCIT] CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Tiocolchicoside [DCIT] CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Tiocolchicoside [DCIT] suppliers with CEP (COS) on PharmaCompass.
A Tiocolchicoside [DCIT] written confirmation (Tiocolchicoside [DCIT] WC) is an official document issued by a regulatory agency to a Tiocolchicoside [DCIT] manufacturer, verifying that the manufacturing facility of a Tiocolchicoside [DCIT] active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Tiocolchicoside [DCIT] APIs or Tiocolchicoside [DCIT] finished pharmaceutical products to another nation, regulatory agencies frequently require a Tiocolchicoside [DCIT] WC (written confirmation) as part of the regulatory process.
click here to find a list of Tiocolchicoside [DCIT] suppliers with Written Confirmation (WC) on PharmaCompass.
Tiocolchicoside [DCIT] Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tiocolchicoside [DCIT] GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tiocolchicoside [DCIT] GMP manufacturer or Tiocolchicoside [DCIT] GMP API supplier for your needs.
A Tiocolchicoside [DCIT] CoA (Certificate of Analysis) is a formal document that attests to Tiocolchicoside [DCIT]'s compliance with Tiocolchicoside [DCIT] specifications and serves as a tool for batch-level quality control.
Tiocolchicoside [DCIT] CoA mostly includes findings from lab analyses of a specific batch. For each Tiocolchicoside [DCIT] CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tiocolchicoside [DCIT] may be tested according to a variety of international standards, such as European Pharmacopoeia (Tiocolchicoside [DCIT] EP), Tiocolchicoside [DCIT] JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tiocolchicoside [DCIT] USP).
